Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis
Abstract Background Due to demographic transition, multimorbidity and high numbers of medicinal products, polypharmacy rates will presumably further increase. This could lead to higher risks of potentially inappropriate medications with potential drug-drug interactions (PDDI). PDDI has already been...
Saved in:
Main Authors: | Christina Dornquast (Author), Mirja Dombrowski (Author), Markus Zabel (Author), Stefan N. Willich (Author), Thomas Reinhold (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022) -
Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022) -
Living With Implantable Cardioverter Defibrillator: A phenomenological Study
by: Mohammad Abbasi, et al.
Published: (2014) -
Living With Implantable Cardioverter Defibrillator: A phenomenological Study
by: Mohammad Abbasi, et al.
Published: (2014) -
Mohs micrographic surgery with magnet suspension of implantable cardioverter defibrillators
by: Danae Trokoudes, et al.
Published: (2024)